What Персен Treats: Main Uses and Benefits

The preparation is used in therapeutic domains that involve mild nervous tension and transient sleep difficulties. As an established therapeutic agent, the medicine is generally applied in contexts marked by increased discomfort or tension. It is relevant for addressing conditions such as mild psychovegetative disorders, increased nervous excitability, and temporary disturbances in falling asleep.

Supportive Relief for Symptoms of Tension

The primary therapeutic use is to help manage symptom clusters related to heightened physiological activity, including irritability, restlessness, and general emotional upset. The medicine is also considered relevant for easing non-specific physical signs of stress, such as minor hand tremors or symptoms related to physical discomfort. This support helps ease the overall symptom burden, particularly during phases of increased distress or discomfort.

“The support provided is relevant during episodes of heightened symptoms, assisting with the manifestations of nervous and physical tension.”

Quick Fact: Relief for Nervous Tension
Main Symptom Domain	Managing symptoms of mild nervous excitement
Symptom Addressed	Helps with temporary difficulties in falling asleep
Benefit	Assists with maintaining functional stability and comfort

The medicine is commonly used when symptoms intensify, requiring short-term symptomatic assistance, and may assist when mental tension interferes with the ability to wind down.

Regulatory References

1. European Union herbal monograph on Valeriana officinalis L., radix

Official Population Eligibility for Персен

Regulatory documents define the eligible user population for Персен (a Valerian, Melissa, Mint combination) based on age, physiological status, and known allergies. Use is established and generally allowed for Adults and the Elderly.

Category	Regulatory Status
Absolute Contraindication	Known Hypersensitivity (allergy) to Valerian, Melissa, Mint, or any other component.
Age Restriction	Not Recommended in Children and Adolescents under 18 years due to insufficient data to establish safety and efficacy.
Physiological Restriction	Not Recommended during Pregnancy and Lactation (breastfeeding), as safety has not been established by regulatory authorities.

Individuals with specific pre-existing conditions require caution. Official labeling states that patients with Liver Problems should seek professional guidance before using the medicine. Additionally, conditional use rules apply to patients with rare hereditary issues like Fructose Intolerance if the specific formulation contains sucrose, as well as those with Alcohol Dependence.

Interactions with other medicines and products

This section outlines the officially documented interaction patterns for the combination phytomedicine Персен, strictly based on regulatory documents from government health authorities. The interaction profile is primarily defined by pharmacodynamic effects and the confirmed absence of documented metabolic interactions.

Pharmacodynamic Reinforcement

Co-administration with other medications that cause drowsiness or sedation is officially addressed due to the risk of additive sedative effects. Specifically, co-medication with synthetic sedatives and hypnotics is not recommended by regulatory bodies, as the pharmacodynamic effects may be reinforced, leading to increased central nervous system depression.

Interactions with Alcohol and Metabolic Pathways

Interaction Type	Official Regulatory Statement
Alcohol (Ethanol)	Co-consumption should be avoided as the sedative effect of the product may be increased by alcohol.
Metabolic Enzymes (CYP450)	No clinically relevant interactions have been observed or documented with drugs metabolized by the major CYP450 enzyme pathways (e.g., CYP 2D6, CYP 3A4/5, CYP 1A2).

Restrictions and Limitations

Regulatory documentation confirms that no specific medicinal products are formally listed as a contraindication in the drug's monographs. Furthermore, official labeling does not mandate specific time separation requirements for any co-administered substances.

Modulation of the Central Inhibitory System

The primary mechanism of action involves the extracts of Valerian and Melissa acting on the GABAergic system, the central nervous system's chief inhibitory pathway. Valerian components are Positive Allosteric Modulators (PAMs) of the GABAA receptor, enhancing its function, while Melissa components inhibit the enzyme GABA Transaminase ( GABA-T), preventing the neurotransmitter's breakdown. This dual mechanism increases and sustains the inhibitory signal, resulting in a reduction of generalized neuronal excitability.

---

Peripheral Smooth Muscle Relaxation

The formula incorporates Mentha Piperita (Peppermint), which provides a complementary action outside the central nervous system. The active component, menthol, inhibits the influx of calcium ions ( Ca^2+) via voltage-gated channels in smooth muscle tissue. This mechanism directly reduces the contractility and tone of peripheral smooth muscles. This action is distinct from the central inhibitory effects and produces a decrease in peripheral smooth muscle tone.

Official Administration Guidelines for Персен (Persen)

The usage of Персен is defined by its form as a solid, fixed-combination phytomedicine, which is administered through the oral route. Official guidelines for its use are structured around the specific purpose of administration and the required duration of the treatment course.

---

Administration and Dosing Schedule

Instruction Entity	Official Administration Guideline
Route of Administration	The product is for oral use only.
Dosing for Tension	Up to three times daily (divided use) is specified for managing symptoms of mild nervous tension.
Dosing for Sleep	A single dose is administered in the evening to aid sleep.
Administration Timing	When taken to aid sleep, the dose should be ingested half an hour to one hour before bedtime.
Pediatric Use	Use is not recommended for children below the age of 12 years due to insufficient data.

---

Procedural Use and Course Duration

To achieve the intended effect, the preparation must be taken with consistency as it is not intended for acute, single-intervention treatment. The official use protocol dictates that treatment involves a period of continued, regular administration.

• Course Duration: Continued use over a period of two to four weeks is recommended to establish an optimal treatment effect.
• Missed Dose Rule: If a dose is missed, the patient should not take a double dose to compensate, but should resume the usual scheduled time for the next administration.

These official instructions standardize the product's use by defining the required oral intake, setting distinct dosing frequencies based on the time of day, and establishing a required minimum duration of treatment.

Research Evidence / Overview of Studies for Персен

Evidence for Use in Transient Sleep Difficulties

The combination of extracts in Персен was evaluated in controlled research settings, including randomized controlled trials (RCTs) and subsequent systematic reviews, applied in studies examining patient-reported experiences of sleep. Researchers primarily focused on conditions characterized by fluctuating or episodic manifestations of sleep difficulty.

These studies monitored outcomes related to sleep initiation and overall perceived quality. Data show patterns related to how patients reported their perceived time needed to fall asleep (sleep latency) when compared to an inactive substance (placebo). Research also explored patient-reported outcomes describing perceived discomfort related to subjective sleep quality and how symptoms evolved in the observed populations over short time intervals.

The evidence level for this area is broadly classified as moderate. Findings were mixed across studies, partly because different trials used different preparations and doses of the herbal extracts. Furthermore, research highlights that while patient-reported experiences are common outcomes, the data for objective measures of sleep, such as those obtained in a sleep lab, remain insufficient.

---

Evidence for Use in Mild Nervous Tension and Restlessness

The combination was studied for how it relates to symptoms of mild nervous excitability and restlessness. This research explored short-term symptom changes and was primarily conducted using short-term RCTs and observational studies during periods of increased symptom activity. Study designs typically compared the extract combination to placebo, often applied in studies examining patient-reported experiences of tension.

Studies monitored outcomes reflecting episodic or acute changes in symptom intensity, such as ratings of irritability and general nervous tension. Research describes patterns observed in the studies related to outcomes monitoring physiological strain or stress over the defined time intervals. This research has contributed to the broader evidence landscape by helping contextualize how patients reported their experience when symptoms become more noticeable.

It is important to note that results apply only to the populations studied and were often focused on examining temporary physiological imbalance. The challenge of objectively measuring subjective mood states means that certainty remains low when describing the consistency of findings across all forms of mild tension.

Key Studies & References European Union herbal monograph on Valeriana officinalis L., radix

Common questions about Персен (FAQ)

Q: Is Персен available in different formulations or strengths?

Official product information states that Персен is typically available in different forms, such as film-coated tablets or hard capsules. The precise strength of each herbal extract (Valerian, Melissa, and Mint) per dose is listed on the product label and in regulatory documents.

Q: Does Персен interact with common over-the-counter pain relievers?

Regulatory texts indicate that no clinically significant interactions have been documented with medicines processed by the major CYP450 enzyme pathways, which includes many common pain relievers. However, a general caution is associated with combining it with any other medicine that may cause drowsiness.

Q: Is there information on combining Персен with prescription antidepressants?

Regulatory sources caution against combining Персен with synthetic sedatives and hypnotics because this may lead to reinforced (additive) sedative effects. Users are advised to be aware of this general precaution when considering co-administration with any prescription medication that affects the central nervous system.

Q: How does the concentration of Valerian in Персен compare to single-ingredient valerian products?

Regulatory documents specify the exact amount of Valerian extract (usually in milligrams) contained within each tablet or capsule of Персен. This dosage information provides a basis for comparison with the quantities stated in single-ingredient valerian products.

Q: Are there any known interactions between Персен and herbal teas or supplements?

Official product information specifically warns against use with alcohol and other synthetic sedative medicines due to potential additive effects. A general caution regarding additive effects may apply to other herbal supplements or teas that are also associated with drowsiness.

Q: Is Персен licensed as a traditional herbal remedy or a pharmaceutical drug?

Персен is officially classified as a non-prescription combination phytomedicine of natural origin. Its specific legal approval status, such as a Traditional Herbal Registration, is defined by the local health authority where the product is sold.

Q: What is the general expectation for the duration of the beneficial effect of Персен?

Regulatory studies and guidance show that the intended beneficial effects are typically noted after the recommended course duration of continuous administration, rather than after a single dose. It is intended to last through a typical dosing interval or night's sleep.

Q: How does the body typically process the herbal components in Персен?

Regulatory documentation summarizes the body's process for handling the herbal components, including how they are absorbed and metabolized. The information indicates that the product does not show clinically relevant interaction with the major CYP450 enzyme pathways for its clearance.

Q: Are there ingredients in Персен that could interact with blood thinning medications?

Official documents note that Персен does not show clinically relevant metabolic interactions with the major drug-processing enzymes. However, given that some herbal products carry a general caution, it is generally recommended that patients taking blood thinning medications consult a healthcare provider regarding all concurrent products.

Q: Does the information describe any potential interaction with grapefruit or grapefruit juice?

Interactions with grapefruit juice primarily involve a specific set of drug-metabolizing enzymes (CYP450). Since official information for Персен states that no clinically relevant interactions involving the major CYP450 pathways have been documented, a specific warning related to grapefruit is generally not mandated.

Q: What is the highest daily amount of Персен that is generally mentioned in official documents?

The maximum recommended daily dose is clearly stated in the official dosing instructions provided by regulatory authorities. This maximum amount is defined based on the intended use, such as for nervous tension or to aid sleep, and is specified in the official dosing instructions.

Q: How quickly is the effect of Персен typically expected to begin?

Regulatory documents typically confirm that Персен is not designed for immediate or acute relief. The full therapeutic effect is typically noted after the product has been taken consistently for the recommended course duration, rather than after a single dose.

Q: Is there any documented information on the potential for tolerance or dependence with Персен?

Official product information and safety documentation do not include warnings regarding tolerance (loss of effect) or dependence. This is consistent with its classification as a mild, non-prescription herbal preparation.

Q: Are there specific warnings for older adults using Персен?

The product is generally allowed for use by adults and the elderly. Official documents list specific warnings only when there is a known increased risk, such as with certain pre-existing conditions.

Q: What should a user do if they notice a potential new side effect while taking Персен?

All patient information leaflets include mandatory instructions regarding adverse events. Official documentation advises users to immediately consult a doctor or pharmacist if they notice any new or concerning side effects, and they are also provided with instructions for reporting these events to the relevant regulatory authority.

Q: Can Персен affect the results of routine medical tests?

Official information on drug interactions typically includes warnings if a product is known to affect the results of routine medical or laboratory tests. The regulatory documents for Персен do not include such a specific warning.

Q: Is a gradual reduction necessary when stopping the use of Персен?

Regulatory guidance does not require specific tapering instructions when discontinuing the use of this product. The absence of mandatory guidance for a gradual reduction indicates that, in most cases, stopping the use can be done immediately.

The storage and disposal instructions for Персен (Persen) are defined by regulatory authorities to maintain the product's stability and ensure safe handling.

Official Storage Conditions

Storage Requirement	Regulatory Statement
Temperature Limit	Store the product at a temperature not exceeding 25°C (77°F).
Protection	Store in the original package to ensure protection from moisture and light.
Child Safety	Keep out of the sight and reach of children.

Official Disposal Rules

Disposal must adhere to specific pharmaceutical waste guidelines. Unused or expired medicinal product must be returned to the pharmacy or a local waste disposal company. The medicine must not be disposed of via wastewater or general household waste, as mandated by environmental protection regulations. Adhering to these instructions ensures proper handling of the product upon expiry.